Das Bundesverfassungsgericht hat die einrichtungsbezogene Corona-Impfpflicht gebilligt.
„Der sehr geringen Wahrscheinlichkeit von gravierenden Folgen einer Impfung steht die deutlich höhere Wahrscheinlichkeit
einer Beschädigung von Leib und Leben vulnerabler Menschen gegenüber“, so die Begründung der Karlsruher Richter, die
damit ihren vorläufigen Entscheidungen in gleicher Sache folgen………..
Auf das Gericht ist Verlass. Merkel hatte mit dem ehemaligen CDU-Fraktionsvize Stephan Harbarth einen ihrer engen Vertrauten an die Spitze des Verfassungsgerichts gesetzt,
das seitdem alles in die Tonne kloppt, was gegen die staatliche Corona-Politik klagt.
Dabei wird oft nicht einmal der Anschein der Unvoreingenommenheit gewahrt.
Die wird u.a. darin deutlich, dass nach Auffassung des Gerichts im aktuellen Fall die weitere Entwicklung der Corona-Pandemie mit der Omikron-Variante keine neue Situation darstellt und somit keine abweichende Beurteilung erfordert.
Es spielt also auch keine Rolle, dass immer mehr Geimpfte schwer erkranken, weil die „Impfungen“ immer mehr an Wirkung verlieren.
Selbst das RKI hat kürzlich Berechnungen zur Impfeffektivität aus seinen Wochenberichten verbannt, offenbar, weil man dort
die Mär von der Wirksamkeit auch mit Tricks und Zahlenspielereien nicht länger aufrecht erhalten kann…………
mehr dazu:
https://www.timepatternanalysis.de/Blog/2022/05/19/das-bvg-und-die-vulnerablen/
Frieden, Freiheit, Eigenverantwortung 
Scenario Design Summary
Aus einem Papier der NTI (Nuclear Threat Initiative) mit dem Namen „Strengthening Global Systems to Prevent and Respond to High-Consequence Biological Threats“, ansässig in Washington DC, veröffentlicht im November 2021, ein im März 2021 gespieltes Szenario durchexerzierend: „ATTACK, May 15 2022, Monkeypox Outbreak in Brinia“, usf. In Zusammenarbeit mit der Munich Security Conference. Das ist empfehlenswert zu lesen.
NTI Paper 9 http://www.nti.orgStrengthening Global Systems to Prevent and Respond to High-Consequence Biological Threats
EXERCISE CO-CHAIRS
Dr. Ernest J. Moniz
Co-Chair and CEO
Nuclear Threat Initiative
Former U.S. Secretary of Energy
Ambassador Wolfgang Ischinger
Chairman
Munich Security Conference
PARTICIPANTS
Mr. Arnaud Bernaert
Head, Health Security Solutions
SICPA
Dr. Beth Cameron
Senior Director, Office of Global Health Security and
Biodefense
U.S. National Security Council
Mr. Luc Debruyne
Strategic Advisor to the CEO
Coalition for Epidemic Preparedness
Dr. Ruxandra Draghia-Akli
Global Head
Johnson & Johnson Global Public Health R&D
Janssen Research & Development
Dr. Chris Elias
President, Global Development Division
Bill & Melinda Gates Foundation
Sir Jeremy Farrar
Director
Wellcome Trust
Dr. George Gao
Director-General, Chinese Center for Disease
Control and Prevention (China CDC)
Vice President, the National Natural Science
Foundation of China (NSFC)
Director and Professor, CAS Key Laboratory of
Pathogenic Microbiology and Immunology, Institute
of Microbiology, Chinese Academy of Sciences
Dean, Medical School, University of Chinese
Academy of Sciences
Dr. Margaret (Peggy) A. Hamburg
Interim Vice President
Global Biological Policy and Programs, Nuclear
Threat Initiative
Former Commissioner of the U.S. Food and Drug
Administration
Dr. Margaret (Peggy) A. Hamburg
Interim Vice President
Global Biological Policy and Programs, Nuclear
Threat Initiative
Former Commissioner of the U.S. Food and Drug
Administration
Ms. Angela Kane
Visiting Professor
Paris School of International Affairs (SciencesPo),
and Tsinghua University
Dr. Emily Leproust
CEO and Co-Founder
Twist Biosciences
Dr. Elisabeth Leiss
Deputy Director of the Governance and Conflict
Division
German Corporation for International Cooperation
(GIZ)
Ms. Izumi Nakamitsu
Under-Secretary-General and High Representative
for Disarmament Affairs
United Nations Office for Disarmament Affairs
Dr. John Nkengasong
Director
Africa Centres for Disease Control and Prevention
Sam Nunn
Founder and Co-Chair
Nuclear Threat Initiative
Former U.S. Senator
Dr. Michael Ryan
Executive Director
WHO Health Emergencies Programme
Dr. Joy St. John
Executive Director
CARPHA
Dr. Petra Wicklandt
Head of Corporate Affairs
Merck KGaA
NTI Paper 8 http://www.nti.orgStrengthening Global Systems to Prevent and Respond to High-Consequence Biological Threats
About the Exercise
I n March 2021, NTI conducted a Tabletop Exercise on Reducing High-Consequence Biological Threats,
the third in a series of annual collaborations between NTI and the Munich Security Conference. The
exercise examined gaps in national and international biosecurity and pandemic preparedness architectures
and explored opportunities to improve capabilities to prevent and respond to high-consequence biological
events. The exercise included 19 senior leaders and experts from across Africa, the Americas, Asia, and
Europe with decades of combined experience in public health, biotechnology industry, international
security, and philanthropy. (See the box on page 9 for the list of exercise participants.)
Exercise Scenario
Developed in consultation with technical and
policy experts, the exercise scenario portrayed a deadly, global pandemic involving an unusual
strain of monkeypox virus that first emerges in the fictional country of Brinia and eventually spreads
globally. Later in the exercise, the scenario reveals that the initial outbreak was caused by a terrorist
attack using a pathogen engineered in a laboratory with inadequate biosafety and biosecurity
provisions and weak oversight. The exercise scenario concludes with more than three billion
cases and 270 million fatalities globally. As part of the scenario development process, NTI conducted
a virtual consultation with experts in December 2020. (See Appendix A for the list of participating
experts.)
The exercise was designed for participants to:
• Discuss requirements for international architectures related to science-based, early assessment of
emerging pandemic risks and timely international warning and alerts for potential pandemics.
• Explore conditions that should trigger national pandemic response actions and discuss strategies
and challenges for scaling public health interventions.
• Consider options to reduce biotechnology risks and strengthen oversight of dual-use bioscience
research.
• Explore opportunities to strengthen international financing mechanisms to bolster global health
security preparedness
Klicke, um auf NTI_Paper_BIO-TTX_Final.pdf zuzugreifen
Interessant!
Gefällt mirGefällt mir